fiteBac SkinCare, LLC Aims to Save Thousands of Lives and Millions in HealthCare Costs

Share Article

Biotechnology firm, fiteBac SkinCare, LLC has created new patent pending technology for life-saving hand hygiene protocols. fiteBac’s Germicidal Hand Gel should help reduce cross contamination of hospital-borne infections, saving lives and providing significant healthcare savings.

Hand Sanitizer

fiteBac SkinCare LLC

The patent pending formula is simple and effective, helping to protect the skin’s natural barrier while providing effective germicidal impact.

fiteBac SkinCare, LLC, a biotechnology company, has introduced the fiteBac SkinCare Germicidal Hand Softening Gel. FiteBac’s scientific team and researchers know there is no other hand sanitizer/germicidal gel that can compare to fiteBac’s SkinCare Germicidal formula. Researchers recognize the product’s unique properties that the Company believes will become the standard of hand hygiene care for healthcare workers in hospitals.

fiteBac’s Germicidal Hand Softening Gel’s innovative combination of helping to protect the skin’s natural moisture barrier with a silicone-based technology and providing an effective germicidal will encourage hand hygiene compliance, because there is no skin damaging alcohol in fiteBac’s formula.. Traditional alcohol based hand sanitizers cause skin damage that results in burning and itching, reducing hand hygiene compliance because of the alcohol burning sensation upon repeated applications.

Recent research discoveries have found many ingredients in most hand sanitizers that worsen the skin’s damaged condition. fiteBac solves many problems of other hand sanitizers. fiteBac Germicidal Hand Softening Gel has no alcohol, no water, no petroleum, no fragrance, or any other agents that many germicidals contain, such as lanolin, mineral oil, glycerin, stearic acid, or propylene glycols. The patent pending formula is simple and effective, helping to protect the skin’s natural barrier while providing effective germicidal impact. fiteBac’s formula is very hydrophobic, yet, allows skin to breathe.

The ultimate success of fiteBac SkinCare Hand Gel will come from saving lives, providing cleaner hospitals and reducing healthcare costs.

About fiteBac™ SkinCare, LLC and KHG. fiteBac SkinCare, LLC is a subsidiary company of Kimmerling Holdings Group, LLC (“KHG”), a Georgia-based biotech company that has developed an antimicrobial platform intellectual property technology.  KHG was founded in 2009 by Kirk Kimmerling, DDS and Dan Kearney. The two set out to create products to "change the world, one product at a time." Kirk and Dan first targeted bacterial issues in dentistry, knowing that solving those problems would lead to dramatic improvements in oral health, and more importantly, systemic bodily health.  They engaged a team of highly accomplished chemists and scientists retired from Fortune 500 companies and researchers from major universities. In doing so, KHG has developed technology with several patents pending that has application well beyond dental materials, and has exciting potential in medical, plastic, composite, coating and other applications that are in various stages of development, some close to commercialization. fiteBac SkinCare Hand Softening Gel is the first product to be released under the fiteBac brand name.  

To learn more about fiteBac SkinCare, visit http://www.fitebac.com or watch our video, http://youtu.be/fsDhp2KA8ds

# # #

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Kirk Kimmerling, President & CEO
Visit website